Search and Discover China Trade Knowledge from Trusted Sources™
Current Language: English
Login
Register
Forgot password?
Home
Start Here
Discover
Popular Search Results
Knowledge Center
Trusted Sources™
Trade Intelligence
Stay Informed
Trade
Directory
Coming Soon
Information
Market
Coming Soon
Sitemap
navigate
About Us
Company
Contact / Blog
Subscribe
Email / RSS
User Center
Search this Author
Sansheng Pharmaceutical sati...
China's private enterprises listed in the United States in recent years has become so rampant. In order to achieve the purpose of listing and financing, an endless stream of innovative methods of ...
Novartis governance suspecte...
As a result of the treatment of constipation Novartis drug Zelnorm (Malay Tegaserod) may lead to cardiovascular disease, the U.S. Food and Drug Administration (FDA) requirements, Novartis will b...
Eli Lilly first quarter prof...
April 16, 2007, the U.S. pharmaceutical company Eli Lilly (NYSE: LLY) announced first quarter 2007 earnings report, profit for the 913.3 million U.S. dollars or 0.84 U.S. dollars / share, exceedin...
The world's best-selling an...
Eli Lilly Company and the German company Boehringer Ingelheim on the 14th held a press conference here, announced a joint marketing in the global scope of the latest antidepressants Baida-yan, an of...
2006 France OTC market to re...
According to IMS statistics, in 2006 France OTC market has reached 1.8 billion euros (about 2.3 billion U.S. dollars), France OTC market in 2006 grew by 8.8 percent, representing a 3 percent decli...
Brazil alleged monopoly Roch...
A few days ago from the Chinese Embassy in Brazil was informed, Brazil protection of economic management committee has announced that as a result of Roche (ROCHE), BASF (BASF) and Sanofi-Aventis...
The international pharmaceut...
With the pharmaceutical market in emerging countries showing a booming trend in these areas will become a transnational pharmaceutical company's future park. The article said that with the expans...
The financing of Chinese ent...
For Chinese enterprises, in order to "drugs" in his capacity as the legally enter the U.S. market, has always been a lot of Chinese medicine enterprise. "First Financial Daily" has recently (Apri...
British AstraZeneca MedImmun...
April 23, the United Kingdom AstraZeneca (AstraZeneca), said it plans to acquire U.S. biotechnology company MedImmune. It is understood that AstraZeneca will be 58 U.S. dollars per share price o...
Wyeth will enter the Chinese...
In China with a well-known Wyeth milk powder (China) Co., Ltd., said yesterday that Wyeth plans to second quarter of next year in China's listed early childhood pneumococcal vaccine (Prevena), ...
Archives
2013
2011
January 2011
February 2011
March 2011
April 2011
May 2011
June 2011
August 2011
2010
January 2010
February 2010
March 2010
April 2010
May 2010
June 2010
July 2010
August 2010
September 2010
October 2010
November 2010
December 2010
2009
January 2009
February 2009
March 2009
April 2009
May 2009
June 2009
July 2009
August 2009
September 2009
October 2009
November 2009
December 2009
2008
January 2008
February 2008
March 2008
April 2008
May 2008
June 2008
July 2008
August 2008
September 2008
October 2008
November 2008
December 2008
2007
January 2007
February 2007
March 2007
April 2007
May 2007
June 2007
July 2007
August 2007
September 2007
October 2007
November 2007
December 2007
2006
April 2006
May 2006
June 2006
July 2006
August 2006
September 2006
October 2006
November 2006
December 2006
Main
sourcejuice
Pharmaceutical Min...
Pharmaceutical M...
Pharmaceutical M...
Privacy Policy
|
Legal
|
Advertising
|
Help
|
Contact us
|
My SourceJuice
Designated brands and trademarks are property of their respective owners. Use of this website constitutes acceptance of SourceJuice.com
Legal
and
Privacy Policy
.
Copyright © 2007 - 2009 SourceJuice.com & SourceJuice All Rights Reserved.